DHR
Danaher Corporation (NYSE: DHR) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $164.6B. Its Maz Rating is 3.82 out of 5 (B+, Buy), ranked against the other companies in its sector.
Factor scores: Valuation 1.40, Growth 3.14, Profitability 4.82, Financial Health 3.23, Momentum 3.82 (as of 2026-10-16).